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ABSTRACT
The aim of this study was to determine the effect of binder and disintegrant excipients toward
tablet properties of levofloxacin as the latter tends to suffer brittle fracture upon compression. The
excipients used were povidone K-30 as the binder and sodium starch glycolate (SSG) as the
disintegrant which the tablets were formulated according to factorial design 22 with two factors
and two levels on each factor. Four formulas were prepared by wet granulation method using 2
and 4% of each povidone K-30 and sodium starch glycolate in various compositions. Tablet
properties were evaluated for its hardness, friability, and disintegration time as well as dissolution
profile. The data obtained was statistically analyzed using Minitab® 17 software to optimize the
formulation and resulted in different impacts caused by each excipient. Povidone K-30 exhibited
an increment in hardness, friability, disintegration time but a decrease indissolution profile of
levofloxacin tablet. SSG decreased hardnessand disintegration time, but increased friability and
dissolution profile of levofloxacin tablet. Overlaid contour plot showed that the optimal formula
regarding tablet properties of friability, disintegration time, and dissolution profile is in
composition of 2.01% povidone K-30 and 2.01% sodium starch glycolate.
Keywords: levofloxacin tablet, povidone K-30, sodium starch glycolate, factorial design.
INTRODUCTION
Commonly used pharmaceutical dosage form is
a tablet and it is available in diverse shapes for
oral purpose (Setyawan et al., 2013). Tablet is
solid dosage form which contains active
pharmaceutical ingredient(s) (APIs) with or
without excipient. It is produced by
compression with high pressure on powder or
granulated mass on a die (Ministry of Health of
the Republic of Indonesia, 2014). Tablet
properties, such as compressibility, friability,
and disintegration time, are influenced by
characteristic of excipients and tableting
process. Excipients such as binder and
disintegration agent can improve tablet
manufacturing process to meet required
specification (Fatmawati et al., 2017). During
compression, both API(s) and excipient(s) can
undergo brittle fracture. Brittle fracture is
direct consequence of stress released from die
wall, tablet powder with low density, and
fracture center during decompression. Particles
with plastic behavior in tablet powder can
absorb stress and improve brittle fracture
(Uhumwangho & Okor, 2004).
Levofloxacin is a synthetic, third-
generation fluoroquinolone antibiotic agent
with broad-spectrum antibacterial activity.
Levofloxacin is used to treat various infections
such as community-acquired pneumonia, acute
exacerbation of chronic bronchitis, acute
maxillary sinusitis, skin and skin structure
infection, urinary infection, and acute
pyelonephritis (Nazir et al., 2013).
Levofloxacin is also known to be slightly
soluble in water and tends to suffer brittle
fracture that can impact its formulation and
dissolution. Levofloxacin is susceptible to
break (fragmented) so that it needs binder to
improve its physical quality and dissolution
rate (Fatmawati et al., 2017).
Polyvinylpyrrolidone, also known as
povidone, is normally used as a binder in wet
granulation process. It is classified to several
types according to its viscosity in aqueous
solution that is called as K-value within range
of 10-120. Wet granulation using povidone K-
30 has characterized to produce harder granules
with better flowability dan lower friability
(Rowe et al., 2009). A correct amount of
binder existed in tablet powder can improve
plasticity and increase interparticulate bonding.
Therefore, tablet compactibility is increased
and tendency for brittle fracture (capping or
laminating) can be eliminated (Uhumwangho
et al., 2006).
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However, increasing binder composition
can impact tablet disintegration time
significantly as disintegration takes longer time
to finish (Chime et al., 2012). To overcome
this problem, disintegration agent (abbreviated
disintegrant) can be added during process.
Disintegrant has major function to reduce the
effect of binder and physical treatment during
compaction. If high binder composition is
present, one should use more effective
disintegrant to release API(s) from the tablet
form (Mohanachandran et al., 2011).
Superdisintegrant, a new class of
disintegrant, is introduced to be more effective
and efficient as it possesses greater
disintegration effect and mechanical strength
(Mohanachandran et al., 2011).
Superdisintegrant acts by absorbing water
then swelling to generate pressure outward and
cause a tablet to break and disintegrate (Shakar
et al., 2012). Sodium starch glycolate (SSG) is
one of superdisintegrant which can be used
both in direct compression and wet granulation
method (Rowe et al., 2009).
Based on aforementioned background, this
research was aimed to determine the effect of
povidone K-30 as binder and SSG as
disintegranton levofloxacin tablet prepared
using wet granulation method. Composition of
povidone K-30 and SSG was varied in each
formula based on factorial design 22.
Parameters evaluated included hardness,
friability, disintegration time, and dissolution
profile. All data obtained then were analyzed
with Minitab® software to depict tablet’s




Materials used in this research were levofloxacin
(Shanghai Terpon Chemical Co., LTD., China),
povidone K-30 (Sigma Aldrich Co., USA), sodium
starch glycolate (Yung ZIP Chemical Co., China),
microcrystalline cellulose (Avicel® PH-101, FMC
Co., USA), and pharmaceutical grade of corn starch,
magnesium stearate, and talc.
Formulation
Formulation was designed according to factorial
design 22 by two factors on two levels for tablet
containing 500 mg of levofloxacin. The factors were
povidone K-30 and SSG at two levels of 2 and 4%
as low andhigh concentration, respectively. Hence,
four formulas were obtained which the compositions
were represented in Table 1. Formula 1 (F1)
consisted of povidone K-30 and SSG in lower
concentration; F2 consisted of povidone K-30 and
SSG in lower and higher concentration,respectively
F3 consisted of povidone K-30 and SSG in higher
and lower concentration, respectively. F4 consisted
of povidone K-30 and SSG in higher concentration.
Tablets were prepared by wet granulation method
with aquadest as solvent added. Granule was dried at
temperature of 50-60C and sieved through mesh
No. 14-20. Tableting was performed using 13 mm
die on tablet hydraulic press by pressure of 9.81 kN.
Then, the tablet was evaluated for its properties by
parameters of hardness, friability, disintegration
time, and also in vitro dissolution.
Table 1. Formulations of levofloxacin tablet (mg)
Compounds Function F1 F2 F3 F4
Levofloxacin API 500 500 500 500
Avicel PH-101 Filler 60 60 60 60
Corn Starch Filler 40 40 40 40
Povidone K-30 Binder 12.73 13.00 26.02 26.59
SSG Disintegrant 12.73 26.02 13.00 26.59
Talk Glidant 6.36 6.50 6.50 6.65
Magnesium stearate Lubricant 4.77 4.88 4.88 4.98
Aquadest Solvent 16 16 16 16
Total 636.59 650.40 650.40 664.81
note: F1 (Formula 1); F2 (Formula 2); F3 (Formula 3); F4 (Formula 4).
Evaluation of Tablet Properties
Tablet hardness, friability, and disintegration time
were measured in three replications to depict tablet
properties. The hardness test was performed using
aErweka hardness tester TBH 220 (Germany) upon
five tablets from each formula. The tablet hardness
was measured in kilogram-force or kilopond (kP).
Value between 4-8 kP is considered to be
acceptable (Fatmawati et al., 2017). The friability
test was carried out on Erweka friability tester TAP
31914 (Germany). A number of tablets weighed
around 6.5 g was rotated at 25 rpm for 4 minutes.
The fines were removed first before re-weighing,
then weight loss percentage was calculated. The
result is acceptable if tablet friability values less than
1% (Türkmen et al., 2018).
The disintegration time was determined with
Erweka disintegrator ZT 501 (Germany) which was
containing a basket rack assembly with six wire-
ended tubes. One tablet was placed in each of six
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tubes, followed by a cover disk, then the basket was
raised and lowered in medium of 900 mL distilled
water attemperature of 37±2°C. Disintegration is
considered to be complete when all tablet fragments
pass through the mesh and acceptable time is below
15 minutes for uncoated tablet (Schmid &
Löbenberg, 2010).
In Vitro Dissolution Test
In vitro dissolution test was conductedusing Erweka
DT 700 (Erweka, Germany) with basket apparatus in
three replicates for each formula. Dissolution
medium used 0.1 N HCl in aqueous solution. Each
tablet of formula 1-4 was added into 900 mL
dissolution medium and stirred at speed of 100 rpm
and temperature of 37 ± 0.5 °C. About 5.0 mL of
dissolution sample was taken at interval of 10, 20,
30, dan 45 minutes then filtered through millipore of
0.45 μm diameter. The filtrate was observed on UV-
Vis spectrophotometer (Hitachi UH5300, Japan) at
maximum wavelength of levofloxacin (λ = 294.98
nm). Obtained absorbance was used to calculate
dissolved levofloxacin using a standard calibration
curve. Each sample was analyzed in triplicate.
Statistical Analysis
The resulting data were analyzed by one-way
analysis of variance (ANOVA) using SPSS 21.0
software (SPSS Inc., USA) with significance limit
was set at alpha < 0.05.Minitab® 17 (Minitab Inc.,
Australia) software was used to determine the
optimum formula for levofloxacin tablet from
hardness, friability, and disintegration time data.
RESULTS AND DISCUSSION
Levofloxacin is known to possess poor
tabletability due to its brittleness. It tends to
suffer brittle fracture during compaction even
with commonly used wet granulation formula
(Fatmawati et al., 2017). Adding excipients
with plastic properties is believed to be able to
overcome brittle fracture issue (Uhumwangho
& Okor, 2004). Therefore, in this study, we
suggested alternative formulation for
levofloxacin tablet that was prepared using wet
granulation method. Factorial design was used
to construct our experiment with two factors
was analyzed for the effect. The factors were
povidone K-30 and SSG as those excipients
has been known to affect the properties of
levofloxacin tablet.The level was determined at
2 and 4 % because it was within concentration
range that allowed in a formulation with
specified function of excipient used (Rowe et
al., 2009).
Factorial design is the design of choice
when experiment is purposed to elucidate the
effect of different factors and conditions on the
result. Its application on pharmaceutical
industry is very useful as the effects of several
factors (A, B, C) and their interactions (ab, bc,
ac, abc) can be determined simultaneously
(Genc & Jalvand, 2008), in this case, with
Minitab® 17 software. The evaluated properties
of levofloxacin tablet are presentedin Table 2.
Four formulas exhibited tablet hardness in
similar value with the lowest one is F3.
However, none these formulas meetthe
requirement for tablet hardness (within 4-8 kP
range). Statistical analysis showed insignificant
differences amongst formulas. Those
phenomena might be influenced by the type of
disintegrant used in this study. Previous study
conducted by Prasad & Duraivel (2012)
showed that using sodium starch glycolate
(Explotab®) can increase tablet hardness of
glimepiride. Furthermore, Explotab® is capable
to generate pellets during wet granulation that
can bind particle when it is dried. Our result
was in agreement with that reference.
Table 2. Result of Tablet Properties Evaluation
Evaluation F1 F2 F3 F4
Hardness (kP) 17.49 ± 0.03 17.49 ± 0.03 16.56 ± 2.07 17.48 ±
0.00
Friability (%) 1.35 ± 0.16 1.30 ± 0.06 1.27 ± 0.37 0.88 ± 0.01
Disintegration Time
(minutes) 8.02 ± 0.23 9.12 ± 0.81 5.91 ± 0.89 4.39 ± 0.10
note: F1 (Formula 1); F2 (Formula 2); F3 (Formula 3); F4 (Formula 4).
The friability test resulted in the similar
percentage of weight loss for all formulas.
Threeout of four formulas showed weight loss
greater than 1 % and only F4 that within the
criteria requirement. Statistical analysis also
indicated that each formula differs
insignificantly (> 0.05). This result might be
due to factor of disintegrant type. A study with
starch pellets and Explotab®produced tablet
with higher friability than other disintegrant
(Mehta et al., 2011).
In the disintegration test, it was observed
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that tablet disintegrated completely less than 10
minutes in four formulas. The result complies
to United States Pharmacopeia (USP) criteria
that disintegration time is less than 15 minutes
(Schmid & Löbenberg, 2010). Every formula
demonstrates statistically significant
differences (< 0.05).
The dissolution profiles are depictedin
Figure 1. Each formula has specific profile,
responding to different composition of
povidone K-30 and SSG. Percentage
ofdissolved levofloxacin for F1, F2, F3, and F4
after45 minutes dissolution test was 93.87 ±
0.67, 89.69 ± 0.60, 105.06 ± 1.40, and 90.68 ±
0.58 %, respectively. This result was used for
further statistical analysis both with ANOVA
and Minitab® software due to compendia
requirement for levofloxacin in tablet dosage
form. dissolution rate at 45 minutes.
Specification of levofloxacin tablet refers to
the United States Pharmacopeia and National
Formulary (USP-NF) which is declared that
concentration of levofloxacin should be more
than 80 % at 45 minutes (The USP Convention,
2011), so that all formulas meet the
requirement. Statistical analysis exhibited
significant differences (< 0.05).
Figure 1. Dissolution profile of levofloxacin tablets in 0.1 N HCl at 37 ± 0.5 °C.
F1 (Formula 1); F2 (Formula 2); F3 (Formula 3); F4 (Formula 4).
Figure 2. Pareto charts of the effect of povidone K-30 (A) dan SSG (B) as individual factor or in
combination (AB) toward levofloxacin tablet properties.
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Statistical analysis was further carried out
using Minitab® 17 software to determine the
effect of the excipients used by graphical
presentation. Pareto chart is used to measure
statistically the effect of adding povidone K-30
and SSG on tablet hardness, friability,
disintegration time, and dissolution and it is
given in Figure 2. A chart that crosses the red
line is assumed to have significant effect on the
parameter calculated. However, as it can be
seen in Figure 2, no graphic crosses the red
line. Thus, pareto chart analysis indicatesthat
povidone K-30 and SSG do not have major
impact on tablet properties and dissolution of
levofloxacin tablet.
Another graphic obtained from Minitab®
17 was main effect plot which shows the
impact of different level in concentration of
povidone K-30 and SSG. Figure 3 shows that
an increase in tablet hardness, friability, and
disintegration time occurs as concentration of
povidone K-30 increases, however a decrease
inpercentage dissolved is observed during 45
min dissolution. It also shows that higher level
of SSG decreases tablet hardness and
disintegration time yet increases friability and
dissolution of the tablet.
Figure 3. Main effect charts of the effect of povidone K-30 and SSG in two levels toward
levofloxacin tablet properties (-1, low level; +1, high level).
Contour plot was also obtained (Figure 4)
and it is used to see 3D relationship between
povidone K-30 and SSG on levofloxacin tablet
properties and dissolution rate. Darker zone
represents higher effect on the test conducted.
In hardness testing, low concentration of SSG
followed by povidone K-30 level increment
can increase tablet hardness. Combination of
high povidone K-30 concentration with higher
concentration of SSG will raise tablet friability.
As for disintegration time, it takes longer on
increasing level of povidone K-30 in high SSG
concentration. Dissolution is enhanced in low
povidone K-30 and higher SSG concentration.
If those contour plots are overlaid together,
it will helpus to predict the optimum formula to
manufacture levofloxacin tablet using povidone
K-30 and SSG as it can be seen in Figure 5.
The overlay excludes hardness data due to the
mismatch of the result to the requirement.
White zone on the graphic is the feasible area,
thus, the optimum composition of povidone K-
30 and SSG for levofloxacin tablet formulation
are 2.01 and 2.01 % respectively.
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Figure 4. Contour plots of the effect of povidone K-30 and SSG in two level on levofloxac in
tablet properties (2.0, low level; 4.0, high level).
Figure 5. Overlaid contour plot of tablet hardness, friability, and dissolution to determine the
optimum formula for levofloxacin tablet.
CONCLUSION
Povidone K-30 and sodium starch glycolate
(SSG) were used in this research to improve
levofloxacin brittleness and were proved to
impact tablet properties and dissolution rate.
Povidone K-30 increases tablet hardness and
friability, lengthens disintegration time, but
reduces dissolution rate. In addition, SSG
reduces tablet hardness, slightly shortens
disintegration time, and increases friability and
dissolution rate. Prediction of the optimum
formulation is allowed from overlaid contour
plot that resulted in composition of 2.01 %
povidone K-30 and 2.01 % SSG to produce
levofloxacin tablet with good tablet properties.
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